Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal, Omar F. Khan, Christopher L. Cooper, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 29
Open Access | Times Cited: 368

Showing 1-25 of 368 citing articles:

mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick Porter, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 4, pp. 261-279
Open Access | Times Cited: 3551
Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2197
Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2122
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 615-632
Open Access | Times Cited: 1028
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 969
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski, Arnab Rudra, Lei Miao, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 710-728
Open Access | Times Cited: 893
Drug delivery systems for RNA therapeutics
Kalina Paunovska, David Loughrey, James E. Dahlman
Nature Reviews Genetics (2022) Vol. 23, Iss. 5, pp. 265-280
Open Access | Times Cited: 812
Advances in Biomaterials for Drug Delivery
Owen S. Fenton, Katy N. Olafson, Padmini S. Pillai, et al.
Advanced Materials (2018) Vol. 30, Iss. 29
Open Access | Times Cited: 729
mRNA vaccine for cancer immunotherapy
Lei Miao, Yu Zhang, Leaf Huang
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 693
Tools for translation: non-viral materials for therapeutic mRNA delivery
Khalid A. Hajj, Kathryn A. Whitehead
Nature Reviews Materials (2017) Vol. 2, Iss. 10
Open Access | Times Cited: 650
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang, Giulietta Maruggi, Hu Shan, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 606
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Lívia P. Mendes, Jiayi Pan, Vladimir P. Torchilin
Molecules (2017) Vol. 22, Iss. 9, pp. 1401-1401
Open Access | Times Cited: 595
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl, Joe J. Senn, Olga Yuzhakov, et al.
Molecular Therapy (2017) Vol. 25, Iss. 6, pp. 1316-1327
Open Access | Times Cited: 589
Advances in the delivery of RNA therapeutics: from concept to clinical reality
James C. Kaczmarek, Piotr S. Kowalski, Daniel G. Anderson
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 579
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch, Edith Jasny, Kim E. Schmidt, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 553
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Lei Miao, Linxian Li, Yuxuan Huang, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 10, pp. 1174-1185
Closed Access | Times Cited: 553
The clinical progress of mRNA vaccines and immunotherapies
Ann Barbier, Allen Yujie Jiang, Peng Zhang, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 840-854
Open Access | Times Cited: 486
Nanomaterial Delivery Systems for mRNA Vaccines
Michael D. Buschmann, Manuel Carrasco, Suman Alishetty, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 65-65
Open Access | Times Cited: 457
Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati, Maxim Shevtsov, Avinash Sonawane
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 441
Recent advances in mRNA vaccine technology
Norbert Pardi, Michael J. Hogan, Drew Weissman
Current Opinion in Immunology (2020) Vol. 65, pp. 14-20
Closed Access | Times Cited: 423
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Giulietta Maruggi, Cuiling Zhang, Junwei Li, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 757-772
Open Access | Times Cited: 414
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 406
Lipids and Lipid Derivatives for RNA Delivery
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 392
Nanotechnology approaches for global infectious diseases
Ameya R. Kirtane, Malvika Verma, Paramesh Karandikar, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 4, pp. 369-384
Closed Access | Times Cited: 389
Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom, Fiona T. van den Berg, Patrick Arbuthnot
Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 117-129
Open Access | Times Cited: 341
Page 1 - Next Page

Scroll to top